Myoepithelioma of Soft Tissues

A Single Institution Retrospective Case Series

Evidio Domingo-Musibay, Andre M. Oliveira, Scott Heitaka Okuno, Ivy A Petersen, Peter S. Rose, Steven Robinson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

BACKGROUND:: Myoepithelioma of the soft tissues is a rare entity and little is known about how best to manage locally recurrent and high-grade disease. Here, we retrospectively examined outcomes of surgery, chemotherapy, and radiation therapy (RT) for treatment of low-grade and high-grade myoepithelioma of soft tissues. METHODS:: We reviewed 20 cases of myoepithelioma of soft tissues seen at Mayo Clinic between 1994 and 2014. The effect of histologic grade and therapies received on relapse and survival were assessed. RESULTS:: We identified 13 patients with low-grade disease and 7 patients with high-grade disease. We found that low-grade disease was frequently effectively managed with surgical resection alone, whereas high-grade disease frequently metastasized and was often fatal. The 5-year event-free survival was 88% (confidence interval, 46%-98%) for low-grade disease versus 36% (confidence interval, 7%-75%; P=0.04) for high-grade disease. The relapse rate in low-grade disease was 29% at 5 years versus 64% (P=0.04) in high-grade disease. No significant responses to chemotherapy were noted, however, excellent responses to perioperative RT were seen. CONCLUSIONS:: Surgery continues as the primary modality of treatment for myoepithelioma of soft tissues. Our study did not show a clear benefit of chemotherapy in the metastatic disease setting, but supports the use of perioperative RT in the management of high-grade disease; further investigation is warranted.

Original languageEnglish (US)
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
DOIs
StateAccepted/In press - Apr 30 2016

Fingerprint

Myoepithelioma
Radiotherapy
Drug Therapy
Confidence Intervals
Recurrence
Disease-Free Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Myoepithelioma of Soft Tissues : A Single Institution Retrospective Case Series. / Domingo-Musibay, Evidio; Oliveira, Andre M.; Okuno, Scott Heitaka; Petersen, Ivy A; Rose, Peter S.; Robinson, Steven.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, 30.04.2016.

Research output: Contribution to journalArticle

@article{6f04b0bc531145cb9dbb0a3ee86470eb,
title = "Myoepithelioma of Soft Tissues: A Single Institution Retrospective Case Series",
abstract = "BACKGROUND:: Myoepithelioma of the soft tissues is a rare entity and little is known about how best to manage locally recurrent and high-grade disease. Here, we retrospectively examined outcomes of surgery, chemotherapy, and radiation therapy (RT) for treatment of low-grade and high-grade myoepithelioma of soft tissues. METHODS:: We reviewed 20 cases of myoepithelioma of soft tissues seen at Mayo Clinic between 1994 and 2014. The effect of histologic grade and therapies received on relapse and survival were assessed. RESULTS:: We identified 13 patients with low-grade disease and 7 patients with high-grade disease. We found that low-grade disease was frequently effectively managed with surgical resection alone, whereas high-grade disease frequently metastasized and was often fatal. The 5-year event-free survival was 88{\%} (confidence interval, 46{\%}-98{\%}) for low-grade disease versus 36{\%} (confidence interval, 7{\%}-75{\%}; P=0.04) for high-grade disease. The relapse rate in low-grade disease was 29{\%} at 5 years versus 64{\%} (P=0.04) in high-grade disease. No significant responses to chemotherapy were noted, however, excellent responses to perioperative RT were seen. CONCLUSIONS:: Surgery continues as the primary modality of treatment for myoepithelioma of soft tissues. Our study did not show a clear benefit of chemotherapy in the metastatic disease setting, but supports the use of perioperative RT in the management of high-grade disease; further investigation is warranted.",
author = "Evidio Domingo-Musibay and Oliveira, {Andre M.} and Okuno, {Scott Heitaka} and Petersen, {Ivy A} and Rose, {Peter S.} and Steven Robinson",
year = "2016",
month = "4",
day = "30",
doi = "10.1097/COC.0000000000000292",
language = "English (US)",
journal = "American Journal of Clinical Oncology: Cancer Clinical Trials",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Myoepithelioma of Soft Tissues

T2 - A Single Institution Retrospective Case Series

AU - Domingo-Musibay, Evidio

AU - Oliveira, Andre M.

AU - Okuno, Scott Heitaka

AU - Petersen, Ivy A

AU - Rose, Peter S.

AU - Robinson, Steven

PY - 2016/4/30

Y1 - 2016/4/30

N2 - BACKGROUND:: Myoepithelioma of the soft tissues is a rare entity and little is known about how best to manage locally recurrent and high-grade disease. Here, we retrospectively examined outcomes of surgery, chemotherapy, and radiation therapy (RT) for treatment of low-grade and high-grade myoepithelioma of soft tissues. METHODS:: We reviewed 20 cases of myoepithelioma of soft tissues seen at Mayo Clinic between 1994 and 2014. The effect of histologic grade and therapies received on relapse and survival were assessed. RESULTS:: We identified 13 patients with low-grade disease and 7 patients with high-grade disease. We found that low-grade disease was frequently effectively managed with surgical resection alone, whereas high-grade disease frequently metastasized and was often fatal. The 5-year event-free survival was 88% (confidence interval, 46%-98%) for low-grade disease versus 36% (confidence interval, 7%-75%; P=0.04) for high-grade disease. The relapse rate in low-grade disease was 29% at 5 years versus 64% (P=0.04) in high-grade disease. No significant responses to chemotherapy were noted, however, excellent responses to perioperative RT were seen. CONCLUSIONS:: Surgery continues as the primary modality of treatment for myoepithelioma of soft tissues. Our study did not show a clear benefit of chemotherapy in the metastatic disease setting, but supports the use of perioperative RT in the management of high-grade disease; further investigation is warranted.

AB - BACKGROUND:: Myoepithelioma of the soft tissues is a rare entity and little is known about how best to manage locally recurrent and high-grade disease. Here, we retrospectively examined outcomes of surgery, chemotherapy, and radiation therapy (RT) for treatment of low-grade and high-grade myoepithelioma of soft tissues. METHODS:: We reviewed 20 cases of myoepithelioma of soft tissues seen at Mayo Clinic between 1994 and 2014. The effect of histologic grade and therapies received on relapse and survival were assessed. RESULTS:: We identified 13 patients with low-grade disease and 7 patients with high-grade disease. We found that low-grade disease was frequently effectively managed with surgical resection alone, whereas high-grade disease frequently metastasized and was often fatal. The 5-year event-free survival was 88% (confidence interval, 46%-98%) for low-grade disease versus 36% (confidence interval, 7%-75%; P=0.04) for high-grade disease. The relapse rate in low-grade disease was 29% at 5 years versus 64% (P=0.04) in high-grade disease. No significant responses to chemotherapy were noted, however, excellent responses to perioperative RT were seen. CONCLUSIONS:: Surgery continues as the primary modality of treatment for myoepithelioma of soft tissues. Our study did not show a clear benefit of chemotherapy in the metastatic disease setting, but supports the use of perioperative RT in the management of high-grade disease; further investigation is warranted.

UR - http://www.scopus.com/inward/record.url?scp=84965014544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965014544&partnerID=8YFLogxK

U2 - 10.1097/COC.0000000000000292

DO - 10.1097/COC.0000000000000292

M3 - Article

JO - American Journal of Clinical Oncology: Cancer Clinical Trials

JF - American Journal of Clinical Oncology: Cancer Clinical Trials

SN - 0277-3732

ER -